Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-30T20:52:21.348Z Has data issue: false hasContentIssue false
  • English
  • Français

The Effect of Lithium on Platelet Monoamine Oxidase Activity in Bipolar and Schizoaffective Disorders

Published online by Cambridge University Press:  29 January 2018

Herbert Y. Meltzer ,
Patricia Tueting  and
Herbert Jackmann
Herbert Y. Meltzer
Affiliation:
Laboratory of Biological Psychiatry
Patricia Tueting
Affiliation:
Illinois State Psychiatric Institute, Department of Psychiatry, University of Chicago Pritzker School of Medicine, 950 East 59th Street, Chicago, Illinois 60637
Herbert Jackmann
Affiliation:
Illinois State Psychiatric Institute, Department of Psychiatry, University of Chicago Pritzker School of Medicine, 950 East 59th Street, Chicago, Illinois 60637
Get access Rights & Permissions [Opens in a new window]

Summary

Platelet monoamine oxidase (MAO) activity was studied in 33 in-patients with bipolar and schizoaffective disorder who were treated with lithium. Platelet MAO activity was found to increase following 10–41 days of lithium treatment compared to a prior drug free period, and the increase was positively correlated with the duration of lithium treatment. The increase in platelet MAO activity was not correlated with clinical improvement as measured by the Brief Psychiatric Rating Scale (BPRS) and the Global Assessment Scale (GAS). The number of platelets per unit of blood was also significantly correlated with the number of days of lithium treatment. However, the increase in the number of platelets in lithium-treated patients was not correlated with the increase in MAO activity and thus appears not to account for it. These results indicate that studies relating platelet MAO activity to psychiatric diagnosis should be interpreted cautiously if patients are receiving lithium carbonate.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 140 , Issue 2 , February 1982 , pp. 192 - 198
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Belmaker, R. H., Ebbeson, K., Ebstein, R. & Rimon, R. (1976) Platelet monoamine oxidase in schizophrenia and manic-depressive illness. British Journal of Psychiatry, 129, 227–32.CrossRefGoogle ScholarPubMed
Berrettini, W. H., Vogel, W. H. & Ladman, R. K. (1979) Effects of lithium on MAO in manic-depressive illness. American Journal of Psychiatry, 36, 836–8.Google Scholar
Billie, P. E., Jensen, M. K., Jensen, J. P. K. & Poulsen, J. C. (1975) Studies on the haematologic and cytogenetic effect of lithium. Acta Medica Scandinavica, 198, 281–6.Google Scholar
Bockar, J., Roth, R. & Heninger, G. (1975) Increased human platelet monoamine oxidase activity during lithium carbonate therapy. Life Sciences, 15, 2109–18.Google Scholar
Brockington, I., Crow, T. J., Johnstone, E. C. & Owen, F. (1976) An investigation of platelet monoamine oxidase activity in schizophrenia and schizoaffective psychosis. In Monoamine Oxidase and its Inhibition, Ciba Foundation Symposium 39, New Series (eds. Wolstenhome, G. E. W. and Knight, J.), pp 353–69. Amsterdam: Elsevier.Google Scholar
Cowdry, R. W. & Goodwin, F. K. (1978) Amine neurotransmitter studies and psychiatric illness: Toward more meaningful diagnostic concepts. In Critical Issues in Psychiatric Diagnosis (eds. Spitzer, R. L. and Klein, D. F.), pp 281—384. New York: Raven Press.Google Scholar
Eckert, B., Gottfries, C.-G., von Knorring, L., Ore-land, L., Wiberg, Å. & Winblad, B. (1980) Brain and platelet monoamine disorders. I. Schizophrenics and cycloid psychotics. Progress in Neuropsychopharmacology, 4, 57—68.Google ScholarPubMed
Edwards, D. J. (1980) Molecular properties of the monoamine oxidase. Schizophrenia Bulletin, 6, 275–81.CrossRefGoogle Scholar
Edwards, D. J., Spiker, D. G., Kupfer, D. J., Foster, F. G., Neil, J. F. & Abrams, L. (1978) Platelet monoamine oxidase in affective disorders. Archives of General Psychiatry, 35, 1443–6.CrossRefGoogle ScholarPubMed
Fieve, R. R., Kimbaraci, T., Kassir, S., Dunner, D. L. & Cote, L. (1980) Platelet monoamine oxidase activity in affective disorder. Biological Psychiatry, 15, 473–8.Google ScholarPubMed
Heninger, G. R., Bockar, J., Roth, R. & Bowers, M. B. (1974) Increased platelet MAO activity during lithium treatment: Relationship to symptom, neuropsychologic, neurophysiologic and CSF neurochemical measurements. Journal of Psychiatric Research, 10, 318.CrossRefGoogle Scholar
Jackman, H. L. & Meltzer, H. Y. (1980) Factors affecting determination of platelet monoamine oxidase activity. Schizophrenia Bulletin, 6, 259–66.CrossRefGoogle ScholarPubMed
Landowski, J., Lysiak, W. & Angulski, S. (1975) Monoamine oxidase activity in blood platelets from patients with cyclophrenic depressive syndromes. Biochemical Medicine, 14, 347–54.CrossRefGoogle ScholarPubMed
Leckman, J. F., Gershon, E. S., Nichols, A. S. & Murphy, D. L. (1977) Reduced MAO activity in first-degree relatives of individuals with bipolar affective disorders. Archives of General Psychiatry, 34, 601–6.CrossRefGoogle ScholarPubMed
Mann, J. (1979) Altered platelet monoamine oxidase activity in affective disorders. Psychological Medicine, 9, 729–36.CrossRefGoogle ScholarPubMed
Medina, J. L., Fareed, J. & Diamond, S. (1980) Lithium carbonate therapy for cluster headache. Changes in number of platelets, and serotonin and histamine levels. Archives of Neurology, 37, 559–63.CrossRefGoogle ScholarPubMed
Murphy, D. L. & Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. The American Journal of Psychiatry, 128, 1351–7.CrossRefGoogle ScholarPubMed
Murphy, D. L., Wright, C., Buchsbaum, M., Nichols, A., Costa, J. L. & Wyatt, R. J. (1976) Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time. Biochemical Medicine, 16, 254–65.CrossRefGoogle Scholar
Nies, A., Robinson, D. S., Harris, L. S. & Lamborn, K. R. (1974) Comparison of monoamine oxidase substrate activity in twins, schizophrenics, depressives and controls. Advances in Biochemical Psychopharmacology, 12, 59—70.Google ScholarPubMed
Orsulak, P. J., Schildkraut, J. J., Schatzberg, A. F. & Herzog, J. M. (1978) Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Biological Psychiatry, 13, 637–47.Google ScholarPubMed
Overall, J. E. & Gorham, D. R. (1962) Brief Psychiatric Rating Scale. Psychological Reports, 10, 799—812.CrossRefGoogle Scholar
Pandey, G. N., Dorus, E. B., Dekirmenjian, H. C. & Davis, J. M. (1975) Effect of lithium treatment on blood catechol-o-methyl transferase and platelet monoamine oxidase in normal subjects. Federal Proceedings, 34, 778.Google Scholar
Reveley, M. A., Glover, V., Sandler, M. & Coppen, A. (1981) Increased platelet monoamine oxidase activity in affective disorders. Psychopharmacology, 73, 257–60.CrossRefGoogle ScholarPubMed
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry, 35, 773–82.CrossRefGoogle ScholarPubMed
Stahl, S. M. (1977) The human platelet. Archives of General Psychiatry, 34, 509–16.CrossRefGoogle ScholarPubMed
Sullivan, J. L., Cavenar, J. O., Maltbie, A. & Stan-field, C. (1977) Platelet-monoamine-oxidase activity predicts response to lithium in manic-depressive illness. The Lancet, ii, 1325–7.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.